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Abstract
Nucleosides play key roles in biology as precursors for salvage pathways of nucleotide synthesis. Prokaryotes import
nucleosides across the cytoplasmic membrane by proton- or sodium-driven transporters belonging to the Concentrative
Nucleoside Transporter (CNT) family or the Nucleoside:H+ Symporter (NHS) family of the Major Facilitator Superfamily.
The high resolution structure of a CNT from Vibrio cholerae has recently been determined, but no similar structural
information is available for the NHS family. To gain a better understanding of the molecular mechanism of nucleoside
transport, in the present study the structures of two conformations of the archetypical NHS transporter NupG from Escherichia
coli were modelled on the inward- and outward-facing conformations of the lactose transporter LacY from E. coli, a member of
the Oligosaccharide:H+ Symporter (OHS) family. Sequence alignment of these distantly related proteins (~ 10% sequence
identity), was facilitated by comparison of the patterns of residue conservation within the NHS and OHS families. Despite
the low sequence similarity, the accessibilities of endogenous and introduced cysteine residues to thiol reagents were found to
be consistent with the predictions of the models, supporting their validity. For example C358, located within the predicted
nucleoside binding site, was shown to be responsible for the sensitivity of NupG to inhibition by p-chloromercuribenzene
sulphonate. Functional analysis of mutants in residues predicted by the models to be involved in the translocation mechanism,
including Q261, E264 and N228, supported the hypothesis that they play important roles, and suggested that the transport
mechanisms of NupG and LacY, while different, share common features.
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Introduction
Many bacteria are able to scavenge low concentrations
of nucleosides from the environment for synthesis of
nucleotides and deoxynucleotides by salvage pathways
of synthesis, and in Escherichia coli nucleosides can be
used as the sole source of nitrogen and carbon for
growth (Munch-Petersen and Mygind 1983, Neuhard
and Nygaard 1987). Uptake across the cytoplasmic
membrane is facilitated by cation-linked transporters
from two evolutionarily unrelated protein families,
the Concentrative Nucleoside Transporter (CNT)
family (designated 2.A.41 in the transporter classiﬁ-
cation database [TCDB; http://www.tcdb.org/]) and
the Nucleoside:H+ Symporter (NHS) family (TCDB
family 2.A.1.10). In E. coli two members of these
families, NupC and NupG respectively, are the
predominant routes for nucleoside uptake; mutants
defective in both the nupC and nupG genes are not
capable of high-afﬁnity nucleoside uptake or growth on
nucleosides as single carbon source (Munch-Petersen
and Mygind 1983). Both of these transporters are
proton-linked but they differ in their permeant selec-
tivity, NupG transporting a wide range of nucleosides
and deoxynucleosides while NupC does not transport
guanosine or deoxyguanosine.
The structure of a homologue of NupC, the
sodium-linked transporter VcCNT from Vibrio
cholerae, has recently been published (Johnson et al.
2012). However, to date no structural information is
available on NupG or any other member of the NHS
family. Thus little is currently known about the
mechanisms of permeant recognition and transport
in this widely-distributed bacterial transporter family.
Correspondence: Dr Vincent L. G. Postis, PhD, Astbury Centre for Structural Molecular Biology, School of Biomedical Sciences, University of Leeds, Leeds LS2
9JT, UK. Tel: +44 (0) 113 3433171. E-mail: v.l.g.postis@leeds.ac.uk
ISSN 0968-7688 print/ISSN 1464-5203 online  2013 Informa UK, Ltd.
DOI: 10.3109/09687688.2012.748939
In the absence of a crystal structure, useful informa-
tion on the likely mechanism of a transporter can
sometimes be gained by modelling the structure on
that of a homologue for which a structure is available.
The NHS family belongs to the major facilitator
superfamily (MFS) and so NupG probably exhibits
a fold similar to those MFS proteins for which a
crystal structure is available. However, homology
modelling is difﬁcult because NupG exhibits only
about 10% sequence identity to the most closely
related MFS transporter of known structure, the
lactose transporter LacY from E. coli (Mirza et al.
2006). The latter belongs to the Oligosaccharide:H+
Symporter (OHS) family (TCDB family 2.A.1.5). In
the present study we have exploited patterns of res-
idue conservation and polarity in the NHS and OHS
families to increase the conﬁdence with which the
NupG and LacY sequences can be aligned, thus
enabling the LacY structure and a predicted alter-
native conformation of the protein to be used as
templates for homology modelling of NupG. The
reliability of the resultant models was assessed by
probing the accessibility of endogenous and intro-
duced cysteine residues to thiol reagents, and the
roles of residues predicted from the model to
be functionally important were investigated via site-
directed mutagenesis and functional assays.
Methods
Materials
E. coli strains XL1-blue and BL21(DE3) were
obtained from Stratagene, La Jolla, CA, USA.
[5,6-3H]uridine (39.5 Ci/mmol) was obtained from
PerkinElmer Life Sciences Ltd, Buckinghamshire,
UK. p-Chloromercuribenzene sulphonate (pCMBS)
was obtained from Toronto Research Chemicals Inc.,
Canada.
Generation of NupG mutants
The plasmid pGJL25, encoding NupG fused in frame
to the C-terminal oligohistidine tag KLAAA-
LEHHHHHH (Xie et al. 2004), was employed as a
template for mutagenesis using the QuikChange
method (Stratagene). The entire NupG open reading
frame of the resultant constructs was sequenced to
conﬁrm the presence of the desired mutation and the
lack of other mutations.
Measurement of nucleoside uptake by bacterial cells
Measurements of [5,6-3H]uridine uptake by E. coli
strain BL21(DE3) cells harbouring pGJL25 and its
derivatives, or the non-recombinant parent vector
pTTQ18 (Stark 1987), were performed at 25C,
essentially as described previously (Xie et al. 2004).
For such experiments, cultures were performed at
37C and with orbital shaking at 200 rpm in
M9 minimal medium (50 mM Na2HPO4, 20 mM
KH2PO4, 10 mM NaCl, 20 mM NH4Cl, 0.2 mM
CaCl2, 2 mM MgSO4) containing carbenicillin
(100 mg/ml) and supplemented with 0.2% (w/v) casa-
mino acids plus 0.2% (w/v) glycerol. When the
cultures had reached a D600nm value of 0.6, expression
was induced by the addition of 0.4 mM isopropyl-b-
D-thiogalactoside (IPTG) and incubation conti-
nued for 1 h unless otherwise stated. Cells were
then washed three times in transport buffer (5 mM
2-(N-morpholino)ethanesulfonicacid (MES), 150mM
KCl, pH 6.6) before measurement of uridine trans-
port. For inhibition experiments, cells were ﬁrst incu-
bated at 25C in transport buffer for 5 min with
N-ethylmaleimide (NEM) or pCMBS and then
washed a further three times in transport buffer before
uridine uptake assays were performed. Typically,
uridine was used at a ﬁnal concentration of 50 mM
and at a speciﬁc radioactivity of 3–5 mCi/mmol. For
estimation of the apparent Vmax and KM values for
transport, permeant concentrations were varied
between 6.25 and 200 mM and an uptake period of
15 s was employed to estimate initial velocities of
transport. Data, expressed per mg dry cell mass, were
corrected for uptake into IPTG-induced cells har-
bouring control vector (pTTQ18) and then kinetic
parameters estimated by non-linear curve ﬁtting to
the Michaelis-Menten equation using OriginPro7
(OriginLab Corporation).
Quantiﬁcation of NupG expression
To quantify the expression of NupG and mutants
thereof in IPTG-induced cultures of E. coli, mem-
branes were prepared by the water lysis procedure
(Ward et al. 2000). Following SDS-polyacrylamide
gel electrophoresis and transfer to nitrocellulose
membranes by electroblotting, the His-tagged protein
was stained with INDIA HisProbe (Pierce) followed
by SuperSignal West Pico chemiluminescent sub-
strate (Perbio Science UK Ltd, Northumberland,
UK). Signals were detected and quantiﬁed using
a GeneGnome Detection system and GeneTools
software respectively (Syngene Bio Imaging).
Modelling of NupG
The sequences of 111 NupG homologues exhi-
biting 24–95% identity to one another were
obtained by BlastP searching the UniProt
protein sequence database and then aligned using
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ClustalX (Thompson et al. 1997), followed by
small manual adjustments using BioEdit (Hall
1999), guided by visual pattern recognition in align-
ments coloured according to residue type. The
same approachwas employed to obtain the sequences
of 99 LacY homologues exhibiting 23–94% identity.
The rate of evolutionary change at each position
in the NupG and LacY sequences was then esti-
mated from phylogenetic analysis of the alignments
using the ConSeq algorithm (Berezin et al. 2004),
and represented using the colour scale shown
in Figure 1.
Figure 1. Sequence alignment of NupG and LacY. The rate of evolutionary change (conservation, ‘c’) and the frequency of residue type
(polarity, ‘p’) at each position in multiple sequence alignments of 111 NupG homologues and of 99 LacY homologues, calculated as described
in theMethods section, are indicated using the colour scales shown. Residues completely or almost completely conserved in all 210 sequences
are indicated by red asterisks. Conserved basic residues of the ‘R-X-G-R-R’ motif are indicated by blue asterisks. Conserved positions
containing aromatic residues (W, Y or F) or residues with small side chains (G, S, A, C, P or T), used to aid alignment of the two sequences, are
indicated by magenta and black asterisks respectively.
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The pattern of residue polarity at each position in
the alignments was also quantiﬁed and likewise
represented as a colour scale (red and yellow, polar
residues [E,D,N,Q,K,R,H,T,S] present in > 20%
or £ 20% of the sequences respectively; green and
turquoise, S or T the only polar residues, and present
in > 20% or £ 20% of the sequences, respectively;
blue, never occupied by a polar residue). The patterns
of residue conservation and polarity were then used
to guide the alignment of the NupG and LacY
sequences, yielding the optimized alignment shown
in Figure 1. Modeller 8v2 (Fiser and Sali 2003) was
then employed to model the structure of NupG on
that of a permeant-free inward-facing conformation of
the C154G mutant of LacY (PDB accession 2CFQ;
(Mirza et al. 2006)), in which the substrate binding
site is open to the cytoplasm. The NupG structure
was also modelled on that of a predicted outward-
facing conformation of LacY, produced by a mole-
cular simulation approach (Pendse et al. 2010), in
which the substrate binding site is open to the peri-
plasm. In each case 100 models were made and the
quality of the ﬁve of lowest energy was assessed using
MolProbity (Davis et al. 2007). The model with the
highest percentage of residues within the most
favoured and allowed regions of the Ramachandran
plot was selected for further study. The models were
visualized using the PyMOL Molecular Graphics
System, Version 0.99rev8, Schrödinger, LLC. The
predicted locations of transmembrane helices were
taken from analysis of the LacY structure using
the Orientations of Proteins in Membranes (OPM)
database (Lomize et al. 2006).
Results
Modelling of NupG
Despite exhibiting very low sequence identities, the
overall folds of those MFS proteins for which struc-
tures are currently available are remarkably similar,
and thus it has been proposed that the known struc-
tures can successfully be employed as templates for
the modelling of distantly-related family members
(Vardy et al. 2004). In the present study, LacY was
employed as such a template for the modelling of the
nucleoside transporter NupG. Although the proteins
exhibit only about 10% sequence identity, they
share similarities in their substrates, these being
disaccharides and nucleosides respectively, and in
their mechanisms, both being proton symporters
(Abramson et al. 2003, Xie et al. 2004). More impor-
tantly, they also share some conserved sequence
motifs. These include absolutely conserved arginine
residues in transmembrane helix 5 (TM5) and TM9,
an almost completely conserved proline residue in the
cytoplasmic loop connecting TM8 and TM9, and an
absolutely conserved aspartate residue in the cyto-
plasmic loop connecting TM2 and TM3 (indicated
with red asterisks in Figure 1). The latter is immedi-
ately upstream of a short motif rich in basic residues
(blue asterisks in Figure 1) that is repeated in modi-
ﬁed form in the loop connecting TM8 and TM9. This
motif, usually designated the R-X-G-R-R motif, is
characteristic of the MFS family and has been shown
to play a role in determining the topology of the
proteins (Sato and Mueckler 1999). Such conserved
motifs allow conﬁdent alignment of the adjacent
regions of NupG and LacY, but lack of sequence
similarity in other regions renders their alignment
more difﬁcult. To aid in the alignment of such
regions, the patterns of residue conservation and
side-chain polarity within the NHS and OHS families,
determined as detailed in the Methods section, were
employed to optimize the alignment. The rationale for
this approach was to generate a model of NupG in
which the exposure of variable positions on the
membrane-facing surface of the model was maxi-
mized and the exposure of hydrophilic residues (other
than serine and threonine, the side chains of which
can hydrogen bond to backbone carbonyl groups in
the same transmembrane helix) and of conserved
positions was minimized. It proved possible to align
numerous conserved positions in the OHS and NHS
multiple sequence alignments, in particular ones in
which either aromatic residues (W, Y or F; magenta
asterisks in Figure 1) or residues with small side
chains (G, S, A, C, P or T; black asterisks
in Figure 1) predominated. Strengthening the validity
of this approach, a similar alignment was obtained
using the proﬁle-proﬁle sequence alignment approach
of Jaroszewski et al. (2011), the only differences
being in the precise alignment of the loop regions
connecting the TM helices. The alignment shown
in Figure 1 was therefore used to generate a model
of NupG based on the crystal structure of LacY in its
inward-facing conformation, with the substrate
binding site open to the cytoplasm, as detailed
in Methods.
The backbone atoms of the ﬁve models of lowest
energy could be superimposed with a root mean-
square deviation (RMSD) of between 0.52 Å and
0.67Å, the major differences between the models
being in the conformation of the longer loops con-
necting the predicted TM helices. Importantly, the
backbone atoms of the residues chosen for subsequent
mutagenesis (see below) could be superimposed
with an average RMSD of 0.15Å, although in
some cases they differed in side chain rotamer. In
the model selected for further analysis, 94.2% of the
Modelling of nucleoside transporter 117
residues were in the most favoured regions of the
Ramachandran plot and 99% were in the allowed
regions. The model exhibited a largely hydrophobic
surface ‘belt’ approximately 30Å thick, largely devoid
of residues with polar side-chains (E, D, Q, N, K, R),
consistent with exposure to the core of the lipid
bilayer (Figure 2). To evaluate the model further,
the residue conservation scores calculated from the
OHS and NHS family multiple sequence alignments
using the ConSeq algorithm were mapped onto the
LacY structure and the NupG model respectively.
Figure 3 shows that in the LacY structure, the
conserved residues are largely clustered at the inter-
faces between TM helices and at the surface of the
hydrophilic substrate-binding cavity, whereas non-
conserved residues predominate in the extramem-
branous loops and on the surface of the TM helices
predicted to interact with the core of the bilayer.
A very similar picture, with a conserved core, was
evident for NupG, supporting the validity of the
model (Figure 3).
Currently, no crystal structure is available for
the outward-facing conformation of LacY in which
the substrate binding site is open to the periplasm,
although the nature of this conformation has been
probed in detail by biochemical and biophysical
approaches (Smirnova et al. 2011). An outward-
facing structure is available for the E. coli fucose
transporter FucP (Dang et al. 2010), but this protein
is more distantly related to NupG than LacY, and in
particular lacks the highly conserved residues men-
tioned above. A model of the outward-facing
structure of LacY based on FucP has been produced
(Radestock and Forrest 2011), but exhibits some
apparent anomalies, such as the orientation of the
absolutely conserved residue R302, which plays a
critical role in the transport mechanism, presumably
reﬂecting the difﬁculty in aligning these distantly
related proteins. Because of similar uncertainty in
the alignment of NupG with FucP, the outward-
facing conformation of NupG was instead modelled
on the predicted outward facing-structure of LacY
itself, produced by a molecular simulation approach
(Pendse et al. 2010). While the results of such model-
ling are clearly more speculative than for modelling
based on a crystal structure, they do allow predictions
of residue accessibility and function to be made,
which can be experimentally tested (see below). In
the best model of the outward-facing conformation
of NupG produced in this manner, 94.7% of the
residues were in the most favoured regions of the
Ramachandran plot and 99% were in the allowed
(a) (b)
(c) (d)
Cytoplasm
30Å
30Å
Cytoplasm
Figure 2. Distribution of polar residues on the surface of a model of NupG based on the inward-facing crystal structure of LacY. (a–d)
Molecular surface representations of the model, viewed from the plane of the membrane, successively rotated by 90 around an axis normal to
the plane of the membrane. The side chain nitrogen and oxygen atoms of aspartate, glutamate, asparagine, glutamine, lysine and arginine
residues are shown in blue and red respectively. The brown rectangles indicate the likely location of the hydrophobic core of the lipid bilayer.
118 H. Vaziri et al.
regions. The model is compared with that of the
inward-facing conformation in Figure 4.
Accessibility of the endogenous cysteine residues of NupG
to the aqueous medium
While the use of proﬁle-proﬁle alignments and anal-
ysis of residue variability in the NHS and OHS
families provided additional conﬁdence for the align-
ment used for modelling, a model based on
only ~ 10% sequence identity between the target
sequence and its structural template must be treated
with caution in the absence of experimental veriﬁca-
tion. To obtain such veriﬁcation, we next sought to
examine the accessibility to water-soluble thiol
reagents of residues predicted by the models to be
exposed at the surface of the predicted permeant-
binding cavity, identiﬁed by analogy with that shown
to bind the lactose homologue b-D-galactopyranosyl-
1-thio-beta-D-galactopyranoside (TDG) in LacY
(Abramson et al. 2003, Mirza et al. 2006).
Wild-type NupG contains four cysteine residues,
each located within the predicted membrane-
spanning region of the protein (Figure 5a, 5b). To
assess the accessibility of these cysteines to the aque-
ous medium, E. coli cells harbouring the expression
plasmid pGJL25 were induced with IPTG to express
NupG and then exposed for 5 min in transport buffer
at pH 6.6 to the membrane-impermeable thiol-
speciﬁc reagent pCMBS. Figure 6a shows that this
reagent caused a concentration-dependent inhibition
of transport, incubation with 100 mM pCMBS reduc-
ing transport to a level even less than that seen in
uninduced cells (Figure 6b). Uridine uptake in the
uninduced cells probably reﬂects the presence of
endogenous NupC and other nucleoside transporters,
because Western blotting revealed the absence of
(a) LacY NupG
Cytoplasm
(b) LacY NupG
Variable Conserved
Figure 3. Pattern of residue conservation in LacY and NupG. The
rate of evolutionary change at each position in the transporters was
calculated using the ConSeq algorithm andmapped onto the crystal
structure of LacY and the corresponding inward-facing model of
NupG respectively using the colour scale indicated. The structures
are shown in cartoon form, with the most variable and conserved
positions in solid molecular representation. (a) View from the plane
of the lipid bilayer and (b) view from the periplasm.
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Figure 4. Comparison of (a) inward- and (b) outward-facing
models of NupG. TM helices 1–12 are numbered and shown in
cartoon form, with evolutionarily-related helices in the N- and
C-terminal halves of the protein being given the same colour.
The grey rectangles indicate the likely location of the hydrophobic
core of the lipid bilayer.
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His-tagged NupG (data not shown and Xie et al.
2004). The inhibition of transport could be
completely reversed by treatment with 100 mM
DTT, demonstrating that the effect of pCMBS prob-
ably reﬂected its reaction with one or more cysteine
residues, likely to be located in NupG (Figure 6b).
The side-chains of residues C16 in TM1 and
C320 in TM10 are predicted by both the inward-
and outward-facing models of NupG to be exposed
on the lipid-facing surface of the transporter, while
that of C75 in TM3 is predicted to be buried at the
interface with TM4 and that of C358 is predicted to
be exposed on the surface of the permeant-binding
cavity (Figure 5a, 5b). The profound effect of pCMBS
on the transport activity of NupG was therefore
hypothesized to result from modiﬁcation of the latter
residue. To investigate this hypothesis further,
C358 was mutated to serine and to alanine, both of
which are found at the equivalent position in NupG
homologues. Both mutants exhibited substantial uri-
dine transport activity (Figure 7a), mutant C358S
showing an apparent Vmax value approximately 80%
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Figure 5. Locations of cysteine residues in NupG. Cross-sections
of the transmembrane regions of (a) the inward-facing and (b) the
outward-facing models of NupG are illustrated, viewed from the
cytoplasmic side of the membrane, showing the locations of the four
cysteine residues of the protein in space ﬁlling representation. TM
helices are shown as a-carbon traces, coloured as in Figure 4.
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Figure 6. Effect of pCMBS treatment on uridine transport in E. coli
cells induced to express wild-type NupG. (a) Concentration-
dependence of the effect of pCMBS on uptake of 50 mM uridine,
measured for 15 s or 2 min as indicated. Results shown are
mean ± SD (n = 3) and have been corrected for uptake into
non-induced cells. (b) Reversibility of pCMBS inhibition by
DTT. Non-induced (control) or induced cells were treated with
or without 100 mMpCMBS for 5 min, washed with transport buffer
and then treated with or without 100 mM DTT for 5 min before
subsequent measurement of 50 mM uridine uptake, over periods of
15 s or 2 min, as indicated. Results shown are mean ± SD (n = 3).
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that of the wild-type protein, and a similar KM value
(Figure 7b and Table I). The ﬁnding that the cysteine
residue is not required for function is consistent with
the fact that alanine is a much more frequent residue
than cysteine at this position in NupG homologues.
However, in contrast to the wild-type protein, the
transport activity of the mutants was not inhibited by
pCMBS treatment (Figure 8a). This ﬁnding indicates
that the inhibition of uridine transport by pCMBS
in bacteria expressing NupG stems from reaction
with the transporter itself, rather than from an
effect on bacterial metabolism and/or the proton
gradient across the membrane, and that residue
C358 is responsible for the sensitivity of NupG to
thiol reagents. Inhibition likely stems from steric
hindrance of nucleoside binding by the bulky reagent.
No protection against inhibition was afforded by
inclusion of 10 mM uridine during incubation with
pCMBS (data not shown), but this may reﬂect the
difﬁculty of competing with the covalent modiﬁcation
of the protein, when using a reversible ligand of
modest afﬁnity.
Use of the substituted cysteine accessibility method
(SCAM) to probe the structure and function of pro-
teins ideally requires a cysteine-free template. In an
attempt to achieve this in the present case, the C358S
mutant was employed as a template to make double
cysteine mutants involving the other three endoge-
nous cysteine residues of NupG. These were mutated
either to alanine (C16 and C320) or to serine (C75),
these residue types being present at the corresponding
locations in NupG homologues. The C358S/C320A
mutant exhibited wild-type kinetic parameters (Table
I). Unfortunately, the double mutants C358S/C16A
and C358S/C75S were expressed at substantially
lower levels than the wild-type protein, and exhibited
lower apparent Vmax values, even following correction
for the reduced expression levels (Table I). Creation
of a cysteine-less template was therefore not pursued,
and it was decided to employ the single cysteine
mutant C358S as a template for further SCAM inves-
tigations because of its nearly wild-type expression
levels and activity, plus insensitivity to inhibition by
pCBMS.
Introduction of additional cysteine residues to test the
model of NupG
Identiﬁcation of C358 as the sole site involved in the
inhibition of NupG by pCMBS was consistent with
the prediction of the model that this position is
accessible to the aqueous medium, being located
on the surface of the putative nucleoside binding
cavity. This ﬁnding thus supports the correctness of
the alignment in the TM11 region used in model
building. Similarly, the lack of involvement of the
other three endogenous cysteine residues of NupG
is consistent with their predicted exposure to the core
of the lipid bilayer or burial at a helix-helix interface,
and thus supports the correctness of the alignment in
the TM1, TM3 and TM10 regions.
To conﬁrm these conclusions, and further investi-
gate the validity of the NupGmodel, cysteine residues
were introduced into the C358S mutant in other
regions where alignment with the LacY sequence
was difﬁcult, in place of residues predicted to be
exposed on the surface of the putative ligand-binding
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Figure 7. Uridine transport activity of NupG C358 mutants. (a)
Uptake of 50 mM uridine, measured for 15 s or 2 min as indicated,
in E. coli cells harbouring vectors encoding wild-type NupG or its
C358A or C358S mutants, before and after induction of expression
by treatment with IPTG for 1 h. Results shown are mean ± SD
(n = 3). (b) Concentration dependence of uridine uptake, measured
over a period of 15 s, in E. coli cells induced to express the C358S
mutant of NupG. Data shown are mean ± SD (n = 3) and have been
corrected for the endogenous uridine uptake activity found in non-
induced cells. The line shows the ﬁt of the data to the Michaelis-
Menten equation, obtained by non linear regression.
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cavity in the models both of the inward-facing and
outward-facing conformations of NupG. These
included TM4 residues L110 and N114, TM5 resi-
due T140, TM7 residue Q225, TM10 residue
N326 and TM11 residue N354 (Figure 8b, 8c). All
of the mutants could be successfully expressed, and all
of them exhibited uridine uptake activity. In most
cases the measured kinetic parameters for transport
were not more than three-fold different from those of
the wild-type protein, indicative of a native or near-
native conformation (Table I). However, the activity
of one mutant, Q225C/C358S, was too low for accu-
rate determination of the Vmax and KM values. In all
but the latter case the transport activity, measured
over an uptake period of 2 min, differed from that of
the parental C358S mutant in being susceptible to
inhibition by pCMBS (Figure 8a), conﬁrming the
predicted accessibility of the residues on the surface
of the ligand-binding cavity (Figure 8b, 8c). For
the L110C, T140C, N326C and N354C mutants,
pCMBS treatment led to essentially complete inhibi-
tion of transport, a situation resembling that seen for
the wild-type protein. However, the N114C mutant
was only partially inhibited (Figure 8a). While no
signiﬁcant inhibition by pCMBS of uptake was seen
in the low activity Q225C/C358S mutant when trans-
port was measured over a period of 2 min, pCMBS
treatmentdidproduceasigniﬁcantdecrease in the initial
rate of uptake, as estimated using an uptake period of
15 sec. These rates, corrected for those seen in unin-
duced cells, were 4.48 ± 0.59 (n = 3) nmol/mg/min and
1.07 ± 0.41 nmol/mg/min (n = 3) before and after
pCMBS treatment, respectively.
Probing the roles of conserved residues in the function
of NupG
The results of investigating the accessibility of endog-
enous and introduced cysteine residues tomodiﬁcation
by pCMBS supported the validity of the models of
NupG created using the distantly related transporter
LacY as a template. The models can therefore reason-
ably be used to provide testable hypotheses concerning
the roles of speciﬁc residues in the translocation
mechanism of NupG, either in nucleoside recognition
or proton translocation. Clearly, retention of activity
in most of the cysteine mutants described above indi-
cates that none of the corresponding residues plays an
essential role in nucleoside transport. In contrast the
mutant Q225C/C358S, despite being expressed at a
level greater than that of the wild-type protein, was
severely impaired in transport activity (Figure 8a),
suggesting that it plays an important role in transporter
structure and/or function.
To identify other residues that might be function-
ally important in permeant recognition, a further set
of mutants was made in the wild-type NupG protein
and their transport functions investigated. Four sites
were chosen for mutagenesis, in TM7 (N228),
TM8 (Q261 and E264) and in TM10 (D323),
because the side-chains of these residues were pre-
dicted by the models to be exposed on the surface of
the putative nucleoside binding cavity (Figure 9b, 9c)
and because they are highly or absolutely conserved
within the NHS family. In the case of the absolutely
conserved residue D323, mutation to asparagine led
to complete failure of protein expression, as revealed
by Western blotting (Figure 9a), even when the
Table I. Kinetic properties of wild-type NupG and its mutants.
NupG mutant Expression level (% wild-type)* Vmax (nmol/mg/min)
† KM (mM)
Wild-type 100 55.1 ± 7.4 24.4 ± 7.2
C358A 121 19.2 ± 3.0 14.9 ± 3.7
C358S 74 44.2 ± 4.9 15.9 ± 2.9
C358S/C16A 15 31.3 ± 4.6 13.7 ± 5.5
C358S/C75S 26 16.5 ± 3.5 14.7 ± 10.4
C358S/C320A 108 62.1 ± 8.4 21.1 ± 6.5
L110C/C358S 78# 41.1 ± 5.4 13.2 ± 4.4
N114C/C358S 33 34.2 ± 4.6 13.7 ± 4.8
T140C/C358S 82 18.4 ± 3.0 53.5 ± 18.5
Q225C/C358S 165 ND ND
N326C/C358S 95 17.8 ± 2.1 16.1 ± 3.4
N354C/C358S 130 36.9 ± 4.2 14.2 ± 3.1
N228C 76 13.0 ± 2.4 83.3 ± 27.6
Q261A 22 20.0 ± 3.4 12.1 ± 7.1
E264Q 147 9.3 ± 1.6 18.5 ± 8.9
E264D 112 18.4 ± 2.6 11.7 ± 3.6
For determination of kinetic parameters, triplicate samples were assayed and the results are shown as mean ± standard error of the estimate.
ND, not determined because transport activity was too low. *Measured by densitometry of Western blots stained for the presence of the C-
terminal His6 tag.
†Vmax values have been normalized to an expression level equivalent to that of the wild-type protein.
#Results shown for 3 h
induction with IPTG, in contrast to 1 h induction for the other mutants.
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expression period was increased from 1–3 h. There-
fore, only background levels of uridine uptake were
seen for this mutant. In contrast, mutation of this
residue to glutamate yielded an expression level and
uridine uptake activity somewhat greater than for
the wild-type transporter, indicating the structural
and/or functional importance of the presence of
a negatively charged side-chain at this position
(Figure 9a). Mutants N228C, Q261A and E264Q
exhibited uridine uptake activities greater than those
seen in uninduced cells, but substantially lower than
that of the wild-type protein (Figure 9a), suggesting
that the corresponding residues play signiﬁcant roles
in transport but are not individually essential for
activity, despite the fact that Q261 and E264 are
absolutely conserved positions in the NHS family.
In the case of residue E264 in TM8, mutation to
aspartate yielded a greater activity than that seen for
the glutamine mutant (Figure 9a), consistent with a
role for the negative charge of the side chain at this
position. The functional importance of all four posi-
tions was conﬁrmed by comparison of the kinetics of
uridine transport by the mutants with that of the wild-
type protein (Table I). This revealed that the Vmax for
transport, when corrected for the expression level, was
substantially reduced (‡ 2.7-fold) in each case, while
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Figure 8. Effect of pCMBS treatment on uridine transport in E. coli cells induced to express cysteine mutants of NupG. (a) Cells induced to
express the indicated mutants were treated with (solid bars) or without (open bars) 100 mM pCMBS for 5 min and then washed with transport
buffer before subsequent measurement of 50 mM uridine uptake, over a period of 2 min. Results shown are mean ± SD (n = 3). (b) Cross-
section of the transmembrane region of the inward-facing NupG model, viewed from the cytoplasmic side of the membrane. (c) Cross-
section of the outward-facing NupG model, viewed from the periplasmic side of the membrane. The locations of the residues replaced by
cysteine are shown in space ﬁlling representation. TM helices are shown as a-carbon traces, coloured as in Figure 4.
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in the case of the N228Cmutant, the apparentKM for
transport was increased 3.4-fold.
Discussion
Homologues of NupG from E. coli are found in a wide
range of eubacteria, including human gut pathogens
such as Salmonella typhimurium, organisms associated
with periodontal disease such as Porphyromonas
gingivalis and Prevotella intermedia, and plant pathogens
in the genus Erwinia. In these organisms, the trans-
porters are likely to play important roles in nucleoside
scavenging from the host environment and also repre-
sent potential routes of uptake for cytotoxic nucleoside
analogues that could be used for treatment of disease.
Distantly related homologues have also been identiﬁed
in humans and other eukaryotes, although their sub-
strates have not yet been established (Xie et al. 2004).
Gaining a greater understanding of the molecular
mechanism of nucleoside recognition and transloca-
tion in NupG therefore has wide biological signiﬁ-
cance, and is potentially of therapeutic relevance.
The key to understanding the mechanism of mem-
brane transporters is knowledge of their structures,
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Figure 9. Comparison of the uridine transport activity of wild-type NupG with that of variants bearing mutations of highly conserved residues
in TM7, TM8 and TM9. (a) Uptake of 50 mMuridine, measured for 15 s or 2 min as indicated, in E. coli cells induced by treatment with IPTG
for 1 h or, in the case of D323N, 3 h, to expressWTNupG or the indicated mutants. Results shown are mean ± SD (n = 3). The panel below the
histogram shows a western blot of membrane samples (20 mg) from the corresponding cultures, stained for the His-tagged NupG protein. (b)
Cross-section of the transmembrane region of the inward-facing NupG model, viewed from the cytoplasmic side of the membrane, and (c)
cross-section of the outward-facing NupG model, viewed from the periplasmic side of the membrane, showing the locations of the mutated
residues, in space ﬁlling representation. TM helices are shown as a-carbon traces, coloured as in Figure 4.
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ideally for each of the conformations associated with
the translocation cycle. Unfortunately, no high reso-
lution structural information is currently available for
NupG, nor have structures been determined for any
closely related members of the MFS of transporters.
In the present study we therefore exploited bioin-
formatic approaches to increase the conﬁdence with
which the NupG sequence could be aligned with the
sequence of the distantly related transporter LacY,
allowing the crystal structure of the inward-facing
conformation of the latter and, more speculatively,
an outward-facing structure of LacY produced by
molecular simulation, to be used as templates for
homology modelling of the nucleoside transporter
structure. We previously used a similar approach,
involving bioinformatic analysis of the much smaller
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Figure 10. Residues predicted to be important in the mechanism of nucleoside transport by NupG. (a) Cross-section of part of the
transmembrane region of the inward-facing NupG model, viewed from the cytoplasmic side of the membrane and (b) cross-section of part of
the transmembrane region of the outward-facing NupG model, viewed from the periplasmic side of the membrane. The locations of residues
likely to play roles in nucleoside recognition and/or proton translocation are indicated. TM helices are shown as a-carbon traces, coloured as
in Figure 4. In (a) an adenosine molecule in space ﬁlling representation has been manually placed, for scale, at a position analogous to that
occupied by TDG in the crystal structure of the inward-facing form of LacY.
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set of NHS and OHS family sequences then available,
to generate a model of the inward-facing confor-
mation of NupG based on the crystal structure of
a complex of LacY with the substrate analogue
b-D-galactopyranosyl-1-thio-b-D-galactopyranoside
(Abramson et al. 2003, Holyoake et al. 2006).
The plausibility of the resultant model was suggested
by its stability during a 15-ns molecular dynamics
simulation in a solvated dimyristoyl phosphatidylcho-
line bilayer, but the model was not tested bioche-
mically (Holyoake et al. 2006). The validity of the
models produced in the present study was supported
by examining the accessibility of endogenous
and introduced cysteine residues, predicted to be
exposed on the surface of a hydrophilic nucleoside
binding cavity, to the bulky water-soluble thiol
reagent pCMBS. In most cases, accessibility to
pCMBS, as revealed by inhibition of uridine trans-
port, was consistent with the predictions of the model
(Figure 8). Apparent lack of accessibility of endoge-
nous cysteines at positions 75, 16 and 320 is also
consistent with the predictions of the models. In the
case of mutant N114C, the observation that loss of
activity produced by pCMBS treatment was only
partial might reﬂect poor accessibility of this residue,
located near the cytoplasmic end of TM4, to extra-
cellular pCMBS. Alternatively, complete modiﬁca-
tion of this site by pCMBS might cause less steric
hindrance to uridine binding than modiﬁcation of
L110C, because of the greater distance of the residue
from the putative binding site. Such possibilities can-
not at present be distinguished, given that modiﬁca-
tion by pCMBS cannot be directly quantiﬁed. In the
case of the TM7 mutant Q225C/C358S, the low
intrinsic activity of the mutant rendered assessment
of accessibility to pCMBS difﬁcult (Figure 8a), but
the reagent was found to have a signiﬁcant inhibitory
effect on the initial rate of uridine uptake, consistent
with the predicted exposure of the side chain on the
surface of the putative nucleoside binding cavity.
The low transport activity of the Q225C/C358S
mutant suggests that Q225 plays an important role in
the structure and/or function of NupG. Such a role
would be consistent with the ﬁnding that 76% of the
111 NupG homologues analyzed in the present study
also contain glutamine at this position. The corre-
sponding residue in LacY, D237 (Figure 1), forms a
salt-bridge with TM11 residue K358. While neither
residue plays an essential role (mutation of both
simultaneously to cysteine or alanine leads to reten-
tion of wild-type activity (Dunten et al. 1993)),
K358 forms a hydrogen bond with the O4’ hydroxyl
of TDG, and D237 is likely to interact with the same
atom via a water molecule (Abramson et al. 2003).
The residue corresponding to LacY residue K358 in
NupG is N354 (Figure 1), but in contrast to the low
activity resulting from mutation of Q225 to cysteine,
mutant N354C/C358S exhibited near wild-type
transport activity (Figure 8a and Table I). This
ﬁnding indicates that, like LacY residue K358, it
does not play a key functional role, despite the
fact that asparagine is found at this position in
75% of the NupG homologues investigated in the
present study.
Additional residues predicted to be of functional
importance from the models and subsequently inves-
tigated by mutagenesis were N228 in TM7, Q261 and
E264 in TM8 and D323 in TM10. Although align-
ment in the TM7 region was difﬁcult, that shown
in Figure 1 suggests that the N228 position, occupied
by asparagine in 71% of the NupG homologues,
corresponds to the highly conserved residue D240
of LacY. The latter forms a salt-bridge with K319 and
is suggested to be involved in the regulation and/
or stabilization of the C-terminal salt-bridge/hydrogen
bond network of LacY involved in proton transloca-
tion (Abramson et al. 2003), although the salt-bridge
is not essential for transport activity (Sahin-Toth et al.
1992). An important, though not essential, functional
role for N228 in NupG, is suggested by the profound
effects of mutagenesis to cysteine on the transport
activity (Table I). While the nature of this role
remains unclear, in both the inward- and outward-
facing models the side chain of this residue is pre-
dicted to form a hydrogen bond with that of
absolutely-conserved TM9 residue R294 (Figure
10a, 10b). The latter corresponds to LacY residue
R302, which plays a key role in proton translocation
but not in permeant recognition (Abramson et al.
2003).
Residues Q261 and E264 in TM8 were investigated
because they are completely conserved in the NHS
family. In Figure 1, Q261 aligns with LacY residue
E269, which is proposed to play key roles in both
permeant and proton translocation. In particular, it
forms a salt-bridge with another essential residue,
R144 in TM5, in the permeant-bound state of the
transporter. The arginine residue in turn forms a
bifurcated hydrogen bond with the O3 and O4 atoms
of the galactopyranosyl ring. The corresponding res-
idue in NupG, R136, is likewise absolutely conserved
and may perhaps play a similar role in binding the
ribose moiety of the nucleoside. The salt bridge
between E269 and R144 in LacY represents a critical
energetic link between the N-terminal domain of
the transporter, which is largely responsible for per-
meant binding, and the C-terminal domain, where
residues involved in proton translocation are located
(Abramson et al. 2003). In contrast to LacY residue
E269, mutation of which to any residue other than
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aspartate abolishes permeant binding and transloca-
tion (Abramson et al. 2003), mutation of NupG
residue Q261 to alanine reduced the Vmax of uridine
transport but did not abolish activity (Table I).
Clearly NupG residue Q261 could not act as a site
of protonation analogous to LacY residue E269, nor
be involved in salt bridge formation. However, such a
role might be contributed by another absolutely con-
served NupG residue, E264, which is located 1 helical
turn away from Q261 in TM8. In support of such a
role, mutation of E264 to glutamine decreased the
Vmax for uridine transport more than 5-fold, a loss in
activity that was partially reversed upon mutation of
the residue to aspartate (Figure 9a and Table I).
Interestingly, the OHS family transporter CscB
from E. coli, which is a sucrose-proton symporter,
similarly lacks an ionizable residue at the position
corresponding to LacY E269, but a glutamate residue
at the position corresponding to E264 of NupG
appears to play a role analogous to that of the LacY
glutamate at position 269 (Vadyvaloo et al. 2006).
The role of a third absolutely conserved NupG
residue, D323 in TM10, is unclear at this stage,
because an asparagine mutant at this position could
not be expressed, although the wild-type activity of
the corresponding glutamate mutant suggests that
the negative charge at this position is important
(Figure 9a). The position aligns with residue P327
of LacY (Figure 1), but it is possible that because of
differences in the conformation of this helix, it is in
fact equivalent to conserved position E325 of the
lactose transporter. The latter plays a critical role in
proton translocation, mutants bearing neutral repla-
cements at this position lacking proton-coupled trans-
port but retaining high-afﬁnity permeant binding and
disaccharide exchange without proton translocation
(Abramson et al. 2003).
Conclusion
The objective of this study was to generate models of
NupG that would be useful in the design and inter-
pretation of experiments aimed at improving our
understanding of nucleoside transport at the mole-
cular level. The validity of the resultant models was
established by experiment, although further improve-
ments might be possible through an iterative cycle of
experimental testing and re-modelling. Similarly, it
would be beneﬁcial in future to test the models further
by molecular dynamics simulations (Holyoake et al.
2006). While only a small subset of conserved resi-
dues was investigated in the present study, the way is
now open for further investigations of the transport
mechanism, for example, to probe the roles of the
absolutely conserved arginine residues at positions
136 and 294. By analogy with the corresponding
residues in LacY, R144 and R302, these may be
involved in nucleoside binding and proton transloca-
tion respectively (Abramson et al. 2003). Similarly,
the potential role of TM10 residue Y318 in proton
translocation could be investigated; this position is
occupied by tyrosine in 75% of the NHS family
members investigated in the present study and by
histidine in the remainder. In LacY, the correspond-
ing residue, H322, plays a key role in coupling proton
translocation and substrate binding (Abramson et al.
2003). Conserved residues, including those experi-
mentally investigated in the present study, which are
predicted from the NupG model to be involved in
permeant recognition and proton translocation are
shown in Figure 10a and 10b.
Further light on the mechanism of permeant rec-
ognition may also be sought by comparative model-
ling of NupG homologues with differing permeant
selectivities. For example, the E. coli xanthosine per-
mease XapB, which exhibits 58% sequence identity to
NupG, transports xanthosine but not guanosine,
while NupG can transport guanosine but not, at
least with high afﬁnity, xanthosine (Norholm and
Dandanell 2001). In contrast to other physiological
nucleosides, xanthosine exists primarily as an anion at
physiological pH values (Kulikowska et al. 2004), and
we hypothesize that the presence of a lysine residue in
XapB in place of L47 in NupG (Figure 10) may be
responsible for the difference in selectivity. This and
other hypotheses should now be addressable by muta-
genesis in the light of models of NupG and its
homologues.
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